Forty Seven Inc (FTSV)
Stock chart
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2020-04-03 | 2020-04-01 | S Sale |
President and CEO Executive Director |
30,237
-86.8%
95.42USD 2,885,236 |
30,237 -86.8% | 95.42 | USD 2,885,236 | |
| 2020-04-03 | 2020-04-01 | S Sale |
President and CEO Executive Director |
2,340
-6.3%
95.41USD 223,268 |
2,340 -6.3% | 95.41 | USD 223,268 | |
| 2020-04-03 | 2020-04-01 | S Sale |
Chief Financial Officer Officer |
1,924
-4.9%
95.43USD 183,598 |
1,924 -4.9% | 95.43 | USD 183,598 | |
| 2020-04-03 | 2020-04-01 | S Sale |
Chief Medical Officer Officer |
79,195
-95.3%
95.42USD 7,556,787 |
79,195 -95.3% | 95.42 | USD 7,556,787 | |
| 2020-03-16 | 2020-03-12 | PS Planned sale | Non-Executive Director |
200
-0.0%
93.74USD 18,748 |
200 -0.0% | 93.74 | USD 18,748 | |
| 2020-03-16 | 2020-03-12 | PS Planned sale | Non-Executive Director |
42,095
-2.3%
93.29USD 3,926,878 |
42,095 -2.3% | 93.29 | USD 3,926,878 | |
| 2020-03-16 | 2020-03-12 | PS Planned sale | Non-Executive Director |
10,800
-0.6%
92.19USD 995,635 |
10,800 -0.6% | 92.19 | USD 995,635 | |
| 2020-03-16 | 2020-03-11 | PS Planned sale | Non-Executive Director |
196,905
-9.8%
94.72USD 18,650,212 |
196,905 -9.8% | 94.72 | USD 18,650,212 | |
| 2020-02-19 | 2020-02-18 | PS Planned sale | Non-Executive Director |
375
-0.0%
45.87USD 17,202 |
375 -0.0% | 45.87 | USD 17,202 | |
| 2020-02-19 | 2020-02-18 | PS Planned sale | Non-Executive Director |
11,420
-1.1%
45.17USD 515,795 |
11,420 -1.1% | 45.17 | USD 515,795 | |
| 2020-02-19 | 2020-02-18 | PS Planned sale | Non-Executive Director |
7,493
-0.7%
44.05USD 330,052 |
7,493 -0.7% | 44.05 | USD 330,052 | |
| 2020-02-19 | 2020-02-18 | PS Planned sale | Non-Executive Director |
5,712
-0.5%
43.15USD 246,466 |
5,712 -0.5% | 43.15 | USD 246,466 | |
| 2020-01-16 | 2020-01-15 | PS Planned sale |
1,011
-0.1%
36.78USD 37,187 |
1,011 -0.1% | 36.78 | USD 37,187 | ||
| 2020-01-16 | 2020-01-15 | PS Planned sale |
23,989
-2.2%
36.33USD 871,511 |
23,989 -2.2% | 36.33 | USD 871,511 | ||
| 2019-12-30 | 2019-12-26 | PS Planned sale |
WEISSMAN IRVING Non-Executive Director |
6,115
-0.3%
44.78USD 273,830 |
6,115 -0.3% | 44.78 | USD 273,830 | |
| 2019-12-30 | 2019-12-26 | PS Planned sale |
WEISSMAN IRVING Non-Executive Director |
23,885
-1.2%
44.08USD 1,052,851 |
23,885 -1.2% | 44.08 | USD 1,052,851 | |
| 2019-12-17 | 2019-12-16 | PS Planned sale |
Majeti Ravindra Non-Executive Director |
7,004
-0.6%
35.87USD 251,226 |
7,004 -0.6% | 35.87 | USD 251,226 | |
| 2019-12-17 | 2019-12-16 | PS Planned sale |
Majeti Ravindra Non-Executive Director |
17,996
-1.6%
35.34USD 635,943 |
17,996 -1.6% | 35.34 | USD 635,943 | |
| 2019-12-11 | 2019-12-10 | PS Planned sale |
Takimoto Chris H Chief Medical Officer Officer |
10,000
-100.0%
35.00USD 350,000 |
10,000 -100.0% | 35.00 | USD 350,000 | |
| 2019-12-10 | 2019-12-09 | PS Planned sale |
WEISSMAN IRVING Non-Executive Director |
10,180
-0.5%
17.25USD 175,646 |
10,180 -0.5% | 17.25 | USD 175,646 | |
| 2019-12-10 | 2019-12-09 | PS Planned sale |
WEISSMAN IRVING Non-Executive Director |
9,820
-0.5%
15.15USD 148,763 |
9,820 -0.5% | 15.15 | USD 148,763 | |
| 2019-12-10 | 2019-12-09 | PS Planned sale |
Majeti Ravindra Non-Executive Director |
20,000
-1.7%
22.00USD 440,000 |
20,000 -1.7% | 22.00 | USD 440,000 | |
| 2019-12-10 | 2019-12-09 | PS Planned sale |
Majeti Ravindra Non-Executive Director |
20,000
-1.7%
20.00USD 400,000 |
20,000 -1.7% | 20.00 | USD 400,000 | |
| 2019-12-10 | 2019-12-09 | PS Planned sale |
Majeti Ravindra Non-Executive Director |
20,000
-1.7%
18.00USD 360,000 |
20,000 -1.7% | 18.00 | USD 360,000 | |
| 2019-12-10 | 2019-12-09 | PS Planned sale |
Majeti Ravindra Non-Executive Director |
5,000
-0.4%
15.00USD 75,000 |
5,000 -0.4% | 15.00 | USD 75,000 | |
| 2019-12-10 | 2019-12-09 | PS Planned sale |
Takimoto Chris H Chief Medical Officer Officer |
10,000
-100.0%
30.00USD 300,000 |
10,000 -100.0% | 30.00 | USD 300,000 | |
| 2019-11-22 | 2019-11-20 | PS Planned sale |
Majeti Ravindra Non-Executive Director |
5,000
-0.4%
12.50USD 62,500 |
5,000 -0.4% | 12.50 | USD 62,500 | |
| 2019-11-20 | 2019-11-18 | PS Planned sale |
15,000
-1.2%
10.26USD 153,915 |
15,000 -1.2% | 10.26 | USD 153,915 | ||
| 2019-08-21 | 2019-08-16 | PS Planned sale |
Takimoto Chris H Chief Medical Officer Officer |
663
-100.0%
6.36USD 4,216 |
663 -100.0% | 6.36 | USD 4,216 | |
| 2019-07-24 | 2019-07-22 | B Purchase |
187,500
+3811.8%
8.00USD 1,500,000 |
187,500 +3811.8% | 8.00 | USD 1,500,000 | ||
| 2019-07-24 | 2019-07-22 | B Purchase |
562,500
+inf%
8.00USD 4,500,000 |
562,500 +inf% | 8.00 | USD 4,500,000 | ||
| 2019-07-24 | 2019-07-22 | B Purchase |
Lightspeed Venture Partners X, L.P. Large shareholder |
312,500
+17.5%
8.00USD 2,500,000 |
312,500 +17.5% | 8.00 | USD 2,500,000 | |
| 2019-07-24 | 2019-07-22 | B Purchase |
Lightspeed Venture Partners X, L.P. Large shareholder |
312,500
+12.6%
8.00USD 2,500,000 |
312,500 +12.6% | 8.00 | USD 2,500,000 | |
| 2019-06-27 | 2019-06-25 | PS Planned sale |
President and CEO Executive Director |
8,199
-11.9%
11.02USD 90,391 |
8,199 -11.9% | 11.02 | USD 90,391 | |
| 2019-06-24 | 2019-06-20 | PS Planned sale |
President and CEO Executive Director |
8,301
-12.0%
11.04USD 91,626 |
8,301 -12.0% | 11.04 | USD 91,626 | |
| 2019-05-22 | 2019-05-20 | PS Planned sale |
President and CEO Executive Director |
1,291
-2.1%
12.46USD 16,080 |
1,291 -2.1% | 12.46 | USD 16,080 | |
| 2019-05-22 | 2019-05-20 | PS Planned sale |
President and CEO Executive Director |
15,209
-20.0%
12.07USD 183,646 |
15,209 -20.0% | 12.07 | USD 183,646 | |
| 2019-05-17 | 2019-05-16 | PS Planned sale |
2,088
-0.1%
16.02USD 33,460 |
2,088 -0.1% | 16.02 | USD 33,460 | ||
| 2019-05-17 | 2019-05-15 | PS Planned sale |
2,223
-0.2%
16.01USD 35,584 |
2,223 -0.2% | 16.01 | USD 35,584 | ||
| 2019-05-07 | 2019-05-03 | PS Planned sale |
Chief Medical Officer |
8,000
-100.0%
17.99USD 143,951 |
8,000 -100.0% | 17.99 | USD 143,951 | |
| 2019-04-30 | 2019-04-26 | PS Planned sale |
20,000
-1.0%
18.35USD 366,978 |
20,000 -1.0% | 18.35 | USD 366,978 | ||
| 2019-04-22 | 2019-04-18 | PS Planned sale |
President and CEO Executive Director |
16,500
-21.4%
18.12USD 299,054 |
16,500 -21.4% | 18.12 | USD 299,054 | |
| 2019-04-17 | 2019-04-15 | PS Planned sale |
25,000
-1.7%
18.30USD 457,505 |
25,000 -1.7% | 18.30 | USD 457,505 | ||
| 2019-04-05 | 2019-04-05 | PS Planned sale |
6,518
-0.3%
17.15USD 111,799 |
6,518 -0.3% | 17.15 | USD 111,799 | ||
| 2019-04-08 | 2019-04-04 | PS Planned sale |
Chief Medical Officer |
8,000
-100.0%
16.39USD 131,105 |
8,000 -100.0% | 16.39 | USD 131,105 | |
| 2019-04-05 | 2019-04-03 | PS Planned sale |
3,382
-0.2%
17.04USD 57,632 |
3,382 -0.2% | 17.04 | USD 57,632 | ||
| 2019-04-02 | 2019-03-29 | PS Planned sale |
100
-0.0%
18.00USD 1,800 |
100 -0.0% | 18.00 | USD 1,800 | ||
| 2019-03-28 | 2019-03-26 | PS Planned sale |
10,000
-0.5%
15.98USD 159,812 |
10,000 -0.5% | 15.98 | USD 159,812 | ||
| 2019-03-21 | 2019-03-19 | PS Planned sale |
President and CEO Executive Director |
16,500
-21.4%
18.15USD 299,401 |
16,500 -21.4% | 18.15 | USD 299,401 | |
| 2019-03-19 | 2019-03-19 | PS Planned sale |
5,292
-0.4%
18.03USD 95,398 |
5,292 -0.4% | 18.03 | USD 95,398 | ||
| 2019-03-19 | 2019-03-18 | PS Planned sale |
9,708
-0.7%
18.02USD 174,938 |
9,708 -0.7% | 18.02 | USD 174,938 | ||
| 2019-03-19 | 2019-03-15 | PS Planned sale |
20,000
-1.3%
17.68USD 353,616 |
20,000 -1.3% | 17.68 | USD 353,616 | ||
| 2019-03-06 | 2019-03-04 | PS Planned sale |
Chief Medical Officer |
8,000
-100.0%
16.94USD 135,550 |
8,000 -100.0% | 16.94 | USD 135,550 | |
| 2019-03-05 | 2019-03-01 | PS Planned sale | Non-Executive Director |
3,616
-0.2%
17.04USD 61,603 |
3,616 -0.2% | 17.04 | USD 61,603 | |
| 2019-02-27 | 2019-02-27 | PS Planned sale | Non-Executive Director |
4,280
-0.2%
17.01USD 72,805 |
4,280 -0.2% | 17.01 | USD 72,805 | |
| 2019-02-27 | 2019-02-26 | PS Planned sale | Non-Executive Director |
12,104
-0.6%
16.93USD 204,973 |
12,104 -0.6% | 16.93 | USD 204,973 | |
| 2019-02-27 | 2019-02-25 | PS Planned sale | Non-Executive Director |
10,000
-0.5%
17.03USD 170,325 |
10,000 -0.5% | 17.03 | USD 170,325 | |
| 2019-02-26 | 2019-02-25 | PS Planned sale | Non-Executive Director |
10,266
-0.7%
16.07USD 164,990 |
10,266 -0.7% | 16.07 | USD 164,990 | |
| 2019-02-26 | 2019-02-22 | PS Planned sale | Non-Executive Director |
22,371
-1.5%
16.01USD 358,131 |
22,371 -1.5% | 16.01 | USD 358,131 | |
| 2019-02-21 | 2019-02-20 | PS Planned sale |
President and CEO Executive Director |
9,410
-13.4%
14.94USD 140,546 |
9,410 -13.4% | 14.94 | USD 140,546 | |
| 2019-02-21 | 2019-02-19 | PS Planned sale |
Chief Medical Officer Officer |
2,500
-100.0%
15.05USD 37,621 |
2,500 -100.0% | 15.05 | USD 37,621 | |
| 2019-02-21 | 2019-02-19 | PS Planned sale |
President and CEO Executive Director |
7,090
-10.5%
15.06USD 106,797 |
7,090 -10.5% | 15.06 | USD 106,797 | |
| 2019-02-05 | 2019-02-04 | PS Planned sale |
Chief Medical Officer Officer |
8,000
-100.0%
14.86USD 118,874 |
8,000 -100.0% | 14.86 | USD 118,874 | |
| 2019-02-05 | 2019-02-04 | PS Planned sale | Non-Executive Director |
6,445
-0.3%
15.02USD 96,805 |
6,445 -0.3% | 15.02 | USD 96,805 | |
| 2019-02-05 | 2019-02-01 | PS Planned sale | Non-Executive Director |
3,219
-0.2%
15.02USD 48,362 |
3,219 -0.2% | 15.02 | USD 48,362 | |
| 2019-02-01 | 2019-01-31 | PS Planned sale | Non-Executive Director |
3,834
-0.3%
14.57USD 55,872 |
3,834 -0.3% | 14.57 | USD 55,872 | |
| 2019-02-01 | 2019-01-30 | PS Planned sale | Non-Executive Director |
16,166
-1.1%
14.46USD 233,683 |
16,166 -1.1% | 14.46 | USD 233,683 | |
| 2019-01-30 | 2019-01-28 | PS Planned sale | Non-Executive Director |
336
-0.0%
15.00USD 5,041 |
336 -0.0% | 15.00 | USD 5,041 | |
| 2019-01-23 | 2019-01-18 | PS Planned sale |
President and CEO Executive Director |
20,000
-68.9%
14.59USD 291,892 |
20,000 -68.9% | 14.59 | USD 291,892 | |
| 2019-01-17 | 2019-01-16 | PS Planned sale | Non-Executive Director |
4,363
-0.3%
16.00USD 69,822 |
4,363 -0.3% | 16.00 | USD 69,822 | |
| 2019-01-17 | 2019-01-15 | PS Planned sale | Non-Executive Director |
23,000
-1.5%
15.73USD 361,808 |
23,000 -1.5% | 15.73 | USD 361,808 | |
| 2019-01-11 | 2019-01-09 | PS Planned sale | Non-Executive Director |
10,000
-0.5%
17.05USD 170,490 |
10,000 -0.5% | 17.05 | USD 170,490 | |
| 2019-01-08 | 2019-01-04 | PS Planned sale |
Chief Medical Officer Officer |
8,000
-100.0%
15.55USD 124,362 |
8,000 -100.0% | 15.55 | USD 124,362 | |
| 2019-01-11 | 2018-12-26 | PS Planned sale | Non-Executive Director |
10,000
-0.5%
15.77USD 157,685 |
10,000 -0.5% | 15.77 | USD 157,685 | |
| 2018-12-28 | 2018-12-26 | PS Planned sale |
McCamish Mark Anthony President and CEO Executive Director |
2,968
-24.7%
15.89USD 47,160 |
2,968 -24.7% | 15.89 | USD 47,160 |